Question 1

What is CytoMed Therapeutics Limited (GDTC)'s latest shareholders’ equity?

Accepted Answer

CytoMed Therapeutics Limited (GDTC)'s shareholders’ equity for FY2025 was $5.1M, as reported in its SEC filings.

Question 2

How has CytoMed Therapeutics Limited (GDTC)'s shareholders’ equity changed year over year?

Accepted Answer

GDTC's shareholders’ equity went from $6.6M in FY2024 to $5.1M in FY2025, a decrease of 22.5%.

Question 3

What is the highest shareholders’ equity CytoMed Therapeutics Limited (GDTC) reported over FY2024–FY2025?

Accepted Answer

The highest reported shareholders’ equity over FY2024–FY2025 was $6.6M, in FY2024.

Question 4

What years does this shareholders’ equity history cover?

Accepted Answer

This page shows GDTC's shareholders’ equity for each fiscal year from FY2024 to FY2025, drawn from SEC XBRL filings.

Fiscal year	Value	YoY
FY2025	$5.1M	-22.5%
FY2024	$6.6M	—

Fiscal year	Value	YoY
FY2025	$5.1M	-22.5%
FY2024	$6.6M	—

CytoMed Therapeutics Limited (GDTC) Shareholders’ equity 2024–2025

More GDTC financial trends